Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing.
JTO Clin Res Rep
; 3(9): 100381, 2022 Sep.
Article
en En
| MEDLINE
| ID: mdl-36082279
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
JTO Clin Res Rep
Año:
2022
Tipo del documento:
Article